Karyopharm Therapeutics, Inc. (KPTI)
1.87
-0.09
(-4.59%)
USD |
NASDAQ |
Aug 24, 16:00
1.87
0.00 (0.00%)
After-Hours: 20:00
Karyopharm Therapeutics Shareholders Equity (Quarterly) : -330.17M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -330.17M |
| March 31, 2026 | -265.65M |
| December 31, 2025 | -292.93M |
| September 30, 2025 | -269.26M |
| June 30, 2025 | -238.93M |
| March 31, 2025 | -205.88M |
| December 31, 2024 | -186.02M |
| September 30, 2024 | -159.65M |
| June 30, 2024 | -132.14M |
| March 31, 2024 | -168.96M |
| December 31, 2023 | -136.21M |
| September 30, 2023 | -100.40M |
| June 30, 2023 | -71.25M |
| March 31, 2023 | -45.17M |
| December 31, 2022 | -16.66M |
| September 30, 2022 | -140.28M |
| June 30, 2022 | -116.34M |
| March 31, 2022 | -83.08M |
| December 31, 2021 | -79.67M |
| September 30, 2021 | -125.98M |
| June 30, 2021 | -83.13M |
| March 31, 2021 | -39.64M |
| December 31, 2020 | 50.55M |
| September 30, 2020 | 83.77M |
| June 30, 2020 | 129.80M |
| Date | Value |
|---|---|
| March 31, 2020 | 166.15M |
| December 31, 2019 | 49.77M |
| September 30, 2019 | 59.87M |
| June 30, 2019 | 82.47M |
| March 31, 2019 | 121.28M |
| December 31, 2018 | 183.17M |
| September 30, 2018 | 171.08M |
| June 30, 2018 | 213.47M |
| March 31, 2018 | 95.53M |
| December 31, 2017 | 129.46M |
| September 30, 2017 | 141.18M |
| June 30, 2017 | 166.71M |
| March 31, 2017 | 138.36M |
| December 31, 2016 | 162.24M |
| September 30, 2016 | 166.93M |
| June 30, 2016 | 153.57M |
| March 31, 2016 | 177.04M |
| December 31, 2015 | 198.36M |
| September 30, 2015 | 220.59M |
| June 30, 2015 | 247.33M |
| March 31, 2015 | 275.52M |
| December 31, 2014 | 206.79M |
| September 30, 2014 | 227.80M |
| June 30, 2014 | 131.68M |
| March 31, 2014 | 144.10M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 523.72M |
| Relay Therapeutics, Inc. | 890.01M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 111.32M |
| Total Liabilities (Quarterly) | 441.48M |
| Debt to Equity Ratio | -0.7759 |
| Current Ratio | 0.7925 |
| Net Debt Paydown Yield | -6.27% |